Catherine A Cukras

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study
    Catherine A Cukras
    Division of Epidemiology and Clinical Applications, National Institutes of Health, Bethesda, Maryland 20892, USA
    Invest Ophthalmol Vis Sci 53:3865-74. 2012
  2. pmc Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time
    Catherine A Cukras
    Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Ophthalmol 130:171-9. 2012
  3. pmc Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial
    Wai T Wong
    Unit on Neuron Glia Interactions in Retinal Disease, Building 6, Room 215, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Invest Ophthalmol Vis Sci 54:2941-50. 2013
  4. pmc Drusen Regression is Associated With Local Changes in Fundus Autofluorescence in Intermediate Age-Related Macular Degeneration
    Brian C Toy
    Unit on Neuron Glia Interactions in Retinal Disease, National Eye Institute, National Institutes of Health, Bethesda, Maryland
    Am J Ophthalmol 156:532-542.e1. 2013

Collaborators

Detail Information

Publications4

  1. pmc Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study
    Catherine A Cukras
    Division of Epidemiology and Clinical Applications, National Institutes of Health, Bethesda, Maryland 20892, USA
    Invest Ophthalmol Vis Sci 53:3865-74. 2012
    ..Study authors investigated the safety and potential efficacy of oral minocycline, a drug capable of inhibiting microglial activation, in the treatment of DME...
  2. pmc Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time
    Catherine A Cukras
    Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Ophthalmol 130:171-9. 2012
    ..Changes in autofluorescence reflect changing fluorophore compositions of lipofuscin and melanin in retinal pigment epithelial cells, which has been hypothesized to contribute to Stargardt disease pathogenesis...
  3. pmc Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial
    Wai T Wong
    Unit on Neuron Glia Interactions in Retinal Disease, Building 6, Room 215, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Invest Ophthalmol Vis Sci 54:2941-50. 2013
    ..To investigate the safety and effects of subconjunctival sirolimus, an mTOR inhibitor and immunosuppressive agent, for the treatment of geographic atrophy (GA)...
  4. pmc Drusen Regression is Associated With Local Changes in Fundus Autofluorescence in Intermediate Age-Related Macular Degeneration
    Brian C Toy
    Unit on Neuron Glia Interactions in Retinal Disease, National Eye Institute, National Institutes of Health, Bethesda, Maryland
    Am J Ophthalmol 156:532-542.e1. 2013
    ..To investigate the association of spontaneous drusen regression in intermediate age-related macular degeneration (AMD) with changes on fundus photography and fundus autofluorescence (FAF) imaging...